Highlights the use of concomitant VA-ECMO and Impella for mechanical circulatory support in a patient with fulminant myocarditis and multi-organ failure.
Answers are grounded in this paper and cite their sources.
Simultaneous short-term MCS including VA-ECMO may aid recovery in fulminant myocarditis; hypothesis-generating and should not yet change practice.
Dear Editor, We would like to present a case of a young male patient with fulminant myocarditis and multi-organ failure treated in our intensive care unit. In the early phase of the treatment, we simultaneously applied mechanical circulatory support (MCS) devices, including veno-arterial extracorporeal membrane oxygenation (ECMO). The use of short-term MCS devices in fulminant myocarditis and in other forms of severe heart failure has increased in recent years The results of some clinical trials indicate that this mode of treatment, when applied in the early phase of cardiogenic shock, yields promising final results
No takes yet. Share an insight, caveat, or question.
Gawda et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: